Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand
- PMID: 8134391
- PMCID: PMC43358
- DOI: 10.1073/pnas.91.6.2300
Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand
Abstract
T-cell activation by an immunogenic peptide can be antagonized by nonstimulatory analogs of that peptide. We investigated this T-cell receptor antagonism by using staphylococcal enterotoxin superantigen to stimulate hemoglobin-specific helper T (Th) cells because its activation pathway may differ from that of conventional antigen. Interestingly, superantigen activation of these Th cells was antagonized by hemoglobin peptide analogs even though agonist (superantigen) and antagonist (analog peptide) bind at different sites on the major histocompatibility complex-encoded molecule and the T-cell receptor. The antagonism appeared to be a fundamental block in T-cell activation, as phosphoinositol generation, cytokine production, and proliferation were reduced in Th1 clones, and, similarly, proliferative and cytokine responses were inhibited in Th2 cells. Even T-cell hybridoma activation (cytokine production and apoptosis) was inhibited by peptide antagonists. Furthermore, analog peptides that functioned as partial agonists for these Th cells also antagonized superantigen-induced proliferation and thus were a subset of the peptide antagonists. In summary, our results demonstrate that analogs of immunogenic peptide are potent antagonists for Th cell responses induced by superantigen as well as immunogenic peptide.
Similar articles
-
Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides.J Immunol. 1993 Apr 15;150(8 Pt 1):3131-40. J Immunol. 1993. PMID: 8468461
-
Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas.J Immunol. 1992 Jan 15;148(2):347-53. J Immunol. 1992. PMID: 1370311
-
Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand.Science. 1991 May 31;252(5010):1308-10. doi: 10.1126/science.1833816. Science. 1991. PMID: 1833816
-
Degenerate recognition and response of human CD4+ Th cell clones: implications for basic and applied immunology.Mol Immunol. 2004 Feb;40(14-15):1089-94. doi: 10.1016/j.molimm.2003.11.009. Mol Immunol. 2004. PMID: 15036913 Review.
-
Regulation of helper T cell responses to staphylococcal superantigens.Eur Cytokine Netw. 2001 Apr-Jun;12(2):210-22. Eur Cytokine Netw. 2001. PMID: 11399508 Review.
Cited by
-
Sensitivity of T cells to antigen and antagonism emerges from differential regulation of the same molecular signaling module.Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5533-8. doi: 10.1073/pnas.0611482104. Epub 2007 Mar 2. Proc Natl Acad Sci U S A. 2007. PMID: 17360359 Free PMC article.
-
Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart.J Exp Med. 1995 Nov 1;182(5):1291-300. doi: 10.1084/jem.182.5.1291. J Exp Med. 1995. PMID: 7595200 Free PMC article.
-
Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands.Eur J Immunol. 2008 Jan;38(1):240-9. doi: 10.1002/eji.200737762. Eur J Immunol. 2008. PMID: 18157812 Free PMC article.
-
Endogenous altered peptide ligands can affect peripheral T cell responses.J Exp Med. 1996 Apr 1;183(4):1311-21. doi: 10.1084/jem.183.4.1311. J Exp Med. 1996. PMID: 8666889 Free PMC article.
-
Modulation of T cell development by an endogenous altered peptide ligand.J Exp Med. 1995 Feb 1;181(2):805-10. doi: 10.1084/jem.181.2.805. J Exp Med. 1995. PMID: 7836933 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases